Adjunctive Therapy
Links shared publicly online about this topic
ingentaconnect Aripiprazole as Adjunctive Therapy for Patients with Major Depres...
ingentaconnect.com — “ingentaconnect Aripiprazole as Adjunctive Therapy for Patients with Major Depres...” View full resource at ingentaconnect.com
Most Recently Shared on January 26, 2011 at 12:24 pm By:
Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder: Overview and Implications of Cli... http://bit.ly/g86S9k
Adjunctive therapy for ADHD approved
pediatricsupersite.com — “The FDA has approved once-daily guanfacine as adjunctive therapy for the treatment of attention-deficit/hyperactivity disorder in children and a” View full resource at pediatricsupersite.com
Most Recently Shared on March 3, 2011 at 8:13 pm By:
Pediatric SuperSite Health Site
Adjunctive therapy for ADHD approved http://ow.ly/47pC1
Immune Modulation as Adjunctive Therapy for Pneumocystis pneumonia
hindawi.com — “Pneumocystis is an opportunistic fungal respiratory pathogen that causes life-threatening pneumonia (Pcp) in patients suffering from defects in cell-mediated immunity, including those with acquired immunodeficiency syndrome (AIDS) and immunosuppression secondary to chemotherapy or organ transplantation. Despite major advances in health care, the mortality associated with Pcp has changed little over the past 25? years. Pcp remains a leading cause of death among HIV infected patients, with mortali” View full resource at hindawi.com
Most Recently Shared on August 29, 2011 at 6:26 pm By:
Drugs and Devices OW OW Health
Immune Modulation as Adjunctive Therapy for Pneumocystis pneumonia: Pneumocystis is an opportunistic fungal resp... http://t.co/avn50sd
Avastin: An Adjunctive Therapy for Proliferative Diabetic Retinopathy
retinaeyedoctor.com — “Easy AdSense by Unreal Avastin is useful for a variety of eye conditions; it is principally used to treat wet macular degeneration and is becoming a popular option to treat diabetic macular edema. On occasion, Avastin has also been useful,” View full resource at retinaeyedoctor.com
Most Recently Shared on January 27, 2010 at 5:02 pm By:
Randall Wong, MD Surgeon, Ophthalmologist, Physician, and Doctor
Avastin to Treat Proliferative Diabetic Retinopathy. New Post. http://bit.ly/dgpQIf
Intuniv gains indication as adjunctive therapy in ADHD - ONA
oncologynurseadvisor.com — “Shire announced that the FDA has approved Intuniv (guanfacine extended-release tablets) for use as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6--17 years as part of a total treatment program.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 28, 2011 at 3:40 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Intuniv gains indication as adjunctive therapy in ADHD http://goo.gl/fb/srbUs
Shire: FDA Oks INTUNIV ER Tablets For Use As Adjunctive Therapy To Stimulants
rttnews.com — “Shire plc (SHP.L, SHPGY) said that the US FDA approved the use of once-daily INTUNIV Extended-Release Tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder, also known as ADHD, in children and adolescents ages 6 to 17 as part of a total treatment program.” View full resource at rttnews.com
Most Recently Shared on February 28, 2011 at 3:18 pm By:
Peter H Brown Doctor and Psychologist
Shire: FDA Oks INTUNIV ER Tablets For Use As Adjunctive Therapy To Stimulants http://bit.ly/dUc4ur #ADHD
Intuniv gains indication as adjunctive therapy in ADHD - MPR
empr.com — “Shire announced that the FDA has approved Intuniv (guanfacine extended-release tablets) for use as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6--17 years as part of a total treatment program.” View full resource at empr.com
Most Recently Shared on February 28, 2011 at 3:44 pm By:
MPR News: Intuniv gains indication as adjunctive therapy in ADHD: Shire announced that the FDA has approved Intu... http://bit.ly/eyR7Gr
PedMedicine: Pediatrics and Medicine: Etanercept as Adjunctive Therapy for Kawasaki Disease?
pedmedicine.blogspot.com — “Health News by an Assistant Professor at University of Chicago, Internist and Allergist” View full resource at pedmedicine.blogspot.com
Most Recently Shared on September 6, 2011 at 3:34 pm By:
Ves Dimov, M.D. Allergist, Physician, Doctor, and Internist
Etanercept as Adjunctive Therapy for Kawasaki Disease? http://t.co/135Z1QI
Banzel Oral Suspension Approved as Adjunct Therapy for Seizures - MPR
empr.com — “The FDA has approved Banzel (rufinamide; Eisai) oral suspension for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients 4 years old.” View full resource at empr.com
Most Recently Shared on March 4, 2011 at 3:28 pm By:
MPR News: Banzel Oral Suspension Approved as Adjunct Therapy for Seizures: The FDA has approved Banzel (rufinami... http://bit.ly/dGLofF
AB Science: Masitinib as an Adjunct Therapy for Alzheimer's Disease - Drugs.com MedNews
drugs.com — “Publication in Alzheimer s Research and Therapy Apr 19, 2011 - AB Science SA (Paris AB)(NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specializin” View full resource at drugs.com
Most Recently Shared on April 19, 2011 at 6:12 pm By:
Drugs and Devices OW OW Health
AB Science: Masitinib as an Adjunct Therapy for Alzheimer's Disease: Publication in Alzheimer's Research a... http://bit.ly/hFt32q #drug
Phosphodiesterase Type 5 Inhibitors as Adjunctive Therapy in the Management of Systolic Heart Failure (December)
theannals.com — “Phosphodiesterase Type 5 Inhibitors as Adjunctive Therapy in the Management of Systolic Heart Failure (December)” View full resource at theannals.com
Most Recently Shared on November 25, 2011 at 3:39 am By:
Phosphodiesterase Type 5 Inhibitors as Adjunctive Therapy in the Management of Systolic Heart Failure (December)... http://t.co/EvwCqKcd
Cholinesterase Inhibitor Adjunctive Therapy for Cognitive Impairment and Depressive Symptoms in Older Adults with Depression (April)
theannals.com — “Cholinesterase Inhibitor Adjunctive Therapy for Cognitive Impairment and Depressive Symptoms in Older Adults with Depression (April)” View full resource at theannals.com
Most Recently Shared on March 14, 2012 at 5:22 am By:
Cholinesterase Inhibitor Adjunctive Therapy for Cognitive Impairment and Depressive Symptoms in Older Adults w... http://t.co/fP8a8Cld
Forest Laboratories And Gedeon Richter Plc Announce Results From A Phase II Study Of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
medicalnewstoday.com — “Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc. announced preliminary top-line results from an 8-week Phase II clinical trial of the novel, investigational antipsychotic agent caripr” View full resource at medicalnewstoday.com
Most Recently Shared on March 1, 2011 at 11:05 am By:
MNT Depression News Health News
Forest Laboratories And Gedeon Richter Plc Announce Results From A Phase II Study Of Cariprazine As Adjunctive Therapy... http://mnt.to/3RJn
Forest Laboratories And Gedeon Richter Plc Announce Results From A Phase II Study Of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
medicalnewstoday.com — “Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc. announced preliminary top-line results from an 8-week Phase II clinical trial of the novel, investigational antipsychotic agent caripr” View full resource at medicalnewstoday.com
Most Recently Shared on March 1, 2011 at 2:20 pm By:
Peter H Brown Doctor and Psychologist
Forest Laboratories And Gedeon Richter Plc Announce Results From A Phase II Study Of Cariprazine As ... http://bit.ly/dP3uss #depression
Eisai to Submit Marketing Authorization Applications in the U.S. and EU for Perampanel as Adjunctive Therapy for Partial Onset Seizuresin Patients with Epilepsy
drugs.com — “Perampanel is a new drug in development for the treatment of partial onset seizures in patients with epilepsy. Perampanel information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on February 8, 2011 at 11:06 pm By:
Drugs and Devices OW OW Health
Eisai to Submit Marketing Authorization Applications in the U.S. and EU for Perampanel as Adjunctive Thera... http://bit.ly/f9NnXc #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Neurology OW
Organizing neurology resources shared by health experts, advocates, and organizations into WisdomCards.
-
Pediatric SuperSite
The official Twitter feed for the PediatricSuperSite, home of Infectious Diseases in Children and Pediatric Annals
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
